- Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study2022 | First Faculty of Medicine
- Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients2017 | First Faculty of Medicine
- Risk Stratification to Predict Renal Survival in Anti-Glomerular Basement Membrane Disease2023 | First Faculty of Medicine